venenis.de

Venenis is a German biotechnology company specializing in the discovery and development of novel peptide therapeutics derived from animal venoms. The company leverages its proprietary venomics platform to identify highly potent and selective peptides that target complex membrane proteins, such as ion channels and G protein-coupled receptors (GPCRs). By optimizing these natural scaffolds, Venenis aims to address significant unmet medical needs in therapeutic areas including chronic pain and inflammatory disorders. The company's approach combines advanced bioinformatics with high-throughput screening to accelerate the transition from venom components to clinical candidates.